Document Detail


Ezetimibe and other azetidinone cholesterol absorption inhibitors.
MedLine Citation:
PMID:  15857308     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Atherosclerotic coronary artery disease remains a major healthcare concern especially in developed countries. While lowering plasma cholesterol levels via diet, exercise, and pharmacotherapy can reduce this risk of developing coronary artery disease, there remains a need for more effective drug therapies. The azetidinone cholesterol absorption inhibitors typified by ezetimibe represent the first new approach to lipid lowering therapy in more than a decade. This review summarizes the medicinal chemistry of the azetidinone cholesterol absorption inhibitors as a class, with emphasis on factors that contributed both to the discovery of ezetimibe as well as to our overall understanding of S.A.R. trends in this area.
Authors:
John W Clader
Related Documents :
18781598 - Reassessing the cardiovascular risks and benefits of thiazolidinediones.
17682928 - Statin therapy for vascular failure.
11090258 - Association of lipoprotein(a), prostaglandin i(2)--synthesis stimulating plasma factor,...
10227778 - Lipoprotein (a) immunapheresis in the treatment of familial lipoprotein (a) hyperlipopr...
23333098 - Nationwide experience of cardio- and cerebrovascular complications during infrainguinal...
3621958 - Impact of hemodynamic monitoring in a medical intensive care unit.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current topics in medicinal chemistry     Volume:  5     ISSN:  1568-0266     ISO Abbreviation:  Curr Top Med Chem     Publication Date:  2005  
Date Detail:
Created Date:  2005-04-28     Completed Date:  2005-06-17     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  101119673     Medline TA:  Curr Top Med Chem     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  243-56     Citation Subset:  IM    
Affiliation:
Department of Cardiovascular and CNS Medicinal Chemistry, Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033-1300, USA. john.clader@spcorp.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticholesteremic Agents / pharmacology*,  therapeutic use
Azetidines / pharmacology*,  therapeutic use
Cholesterol / blood*,  metabolism
Coronary Disease / etiology,  mortality,  prevention & control
Drug Therapy, Combination
Humans
Intestinal Absorption / drug effects*
Structure-Activity Relationship
Chemical
Reg. No./Substance:
0/Anticholesteremic Agents; 0/Azetidines; 163222-33-1/ezetimibe; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New lipid-lowering agents acting on LDL receptors.
Next Document:  Cholesteryl ester transfer protein: pharmacological inhibition for the modulation of plasma choleste...